Checkpoint Inhibitor
Nivolumab +/− Stereotactic Radiosurgery for Chordoma
Recruiting1 awardPhase 1
Baltimore, Maryland
This trial is studying nivolumab with or without SRS to treat patients with chordoma. Nivolumab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. SRS is a specialized radiation therapy that delivers a single, high dose of radiation directly to the tumor.
Radiation
Nilotinib + Radiation for Chordoma
Recruiting1 awardPhase 1
Boston, Massachusetts
This trial is testing a drug, nilotinib, to see if it can help shrink tumors when used with radiation therapy. Researchers want to see if it is safe and what the highest dose is that can be given without causing severe side effects.
Popular Filters
Trials With No Placebo
Cell Depletion
Zoledronic Acid for Cancer
Recruiting1 awardPhase 1 & 2
Gainesville, Florida
This trial will test a new treatment for pediatric and young adult patients with certain types of solid tumors. The treatment involves using a special type of stem cell transplant that has been depleted of certain immune cells,
Checkpoint Inhibitor
Tazemetostat + Immunotherapy for Cancer
Recruiting1 awardPhase 1 & 2
Boston, Massachusetts
This trial tests a combination of three drugs to treat children with specific hard-to-treat cancers. The drugs work by blocking cancer growth and boosting the immune system. The study aims to find the safest dose and see if the combination is effective.
Monoclonal Antibodies
Cetuximab for Chordoma
Recruiting1 awardPhase 2
Houston, Texas
This trial is testing cetuximab, a medication that blocks a protein on cancer cells, in adults with advanced or metastatic chordoma. These patients have cancers that cannot be surgically removed or have spread to other parts of the body. The goal is to see if cetuximab can help stop the cancer from growing and spreading. Cetuximab is approved for various cancers including colorectal and head and neck cancers.
Monoclonal Antibodies
BCA101 + Pembrolizumab for Cancer
Recruiting1 awardPhase 1
Boston, Massachusetts
This trial is testing BCA101, a new drug that targets specific cancer growth proteins, in patients with advanced cancers that haven't responded to other treatments. The drug works by blocking proteins that help the cancer grow and spread.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.